Search - tctmd.com

Displaying 41 - 60 of 468

Sort: Relevancy | Date

Presentation TCT 2024

TCT 421: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents in U.S. Patients Undergoing Coronary Revascularization: 2-Year Outcomes From the BIOFLOW-VII Trial

Presenter: David Kandzari

October 28, 2024

Presentation TCT 2024

A Randomized Comparison Between Selution SLR™ Sirolimus-Eluting Balloon and Plain Old Balloon Angioplasty in Patients With Distal Internal Pudendal-Penile Artery Disease and Erectile Dysfunction: The PERFECT-SELUTION First-in-Man Study

Presenter: Tzung-Dau Wang

October 28, 2024

Presentation TCT 2024

TCT 444: Angiographic Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

Presenter: Kiril Karamfiloff

October 28, 2024

Presentation TCT 2024

Magnesium-Based Resorbable Scaffold vs Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: Final 5-Year Results of the MAGSTEMI Randomized Controlled Trial

Presenter: Manel Sabate

October 27, 2024

Presentation TCT 2024

TCT 363: Five-Year Clinical Outcomes of Patients Treated With the XINSORB Bioresorbable Sirolimus-Eluting Scaffolds

Presenter: Jiasheng Yin

October 27, 2024

Presentation TCT 2024

TCT 364: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions: 5 Clinical Year Outcomes

Presenter: Matthias Lutz

October 27, 2024

News Conference News ESC 2024

REC-CAGEFREE I: DCB Fails to Match Up to DES for De Novo CAD

Todd Neale

September 09, 2024

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

News Conference News EuroPCR 2024

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Michael O'Riordan

May 28, 2024

Presentation EuroPCR 2024

Patient and procedure characteristics for 1000 Selution SLRTM sirolimus-eluting balloon procedures

Presenter: Simon Eccleshall

May 14, 2024

Presentation EuroPCR 2024

Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study

Presenter: Alexandre Abizaid

May 14, 2024

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Caitlin E. Cox

October 27, 2023

Presentation TCT 2023

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

Presenter: Kirstine Hansen

October 25, 2023

Presentation TCT 2023

TCT 522: Ultrathin Strut Biodegradable Polymer-coated Sirolimus-eluting Stents in an All-comers Patient Population – The Prospective S-FLEX UK-II Registry

Presenter: Azfar Zaman

October 25, 2023

Presentation TCT 2023

TCT 708: Five-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stents With Biodegradable Polymer. From the SORT OUT VII Trial

Presenter: Jens Trøan

October 25, 2023

Presentation TCT 2023

Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial

Presenter: Juan Iglesias

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

Presentation TCT 2023

TCT 761: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 18 Month Outcomes – FANTOM STEMI Pilot Study

Presenter: Lukasz Koltowski

October 25, 2023

Presentation TCT 2023

TCT 575: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24 Month Clinical Outcomes in First 100 Patients

Presenter: Matthias Lutz

October 25, 2023

Advertisement

TCT 421: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents in U.S. Patients Undergoing Coronary Revascularization: 2-Year Outcomes From the BIOFLOW-VII Trial

A Randomized Comparison Between Selution SLR™ Sirolimus-Eluting Balloon and Plain Old Balloon Angioplasty in Patients With Distal Internal Pudendal-Penile Artery Disease and Erectile Dysfunction: The PERFECT-SELUTION First-in-Man Study

TCT 444: Angiographic Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

Magnesium-Based Resorbable Scaffold vs Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: Final 5-Year Results of the MAGSTEMI Randomized Controlled Trial

TCT 363: Five-Year Clinical Outcomes of Patients Treated With the XINSORB Bioresorbable Sirolimus-Eluting Scaffolds

TCT 364: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions: 5 Clinical Year Outcomes

REC-CAGEFREE I: DCB Fails to Match Up to DES for De Novo CAD

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Patient and procedure characteristics for 1000 Selution SLRTM sirolimus-eluting balloon procedures

Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

TCT 522: Ultrathin Strut Biodegradable Polymer-coated Sirolimus-eluting Stents in an All-comers Patient Population – The Prospective S-FLEX UK-II Registry

TCT 708: Five-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stents With Biodegradable Polymer. From the SORT OUT VII Trial

Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

TCT 761: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 18 Month Outcomes – FANTOM STEMI Pilot Study

TCT 575: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24 Month Clinical Outcomes in First 100 Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content